News, Short Squeeze, Breakout and More Instantly...
– Q1 2022 Total Revenue of $80.4 million – Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three months ended March 31, 202...
Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2022 financial results after market close on Thursday, May 5, 2022. The Company will host a correspo...
Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 21 st Annual Needham Virtual Healthcare Conference. Inog...